• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® RUB IGG II

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® RUB IGG II Back to Search Results
Catalog Number 30221
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/17/2019
Event Type  malfunction  
Event Description
A customer in (b)(6) reported a false positive result in association with the vidas® rub igg ii assay.The customer reported that on (b)(6) 2019, the isolate was first tested on dxi (beckman) and was negative (9.28 ui/).Using the vidas 3 instrument, the isolate was first run in position d1 and the result was positive (55 ui/ml).The repeat test was in position a1 and the result was negative (8 ui/ml).A retest on dxi gave a negative result (9.84 ui/ml).The customer reported that no wrong result was reported to the physician.There is no indication or report from the hospital or treating physician to biomérieux that the discrepant result led to any adverse event related to the patient's state of health.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
An internal investigation was performed for a false positive result in association with the vidas® rub igg ii assay.Batch history records and trend analysis: there is no other complaint on this batch for the same issue.There is no capa, or non-conformity linked with the customer 's complaint.The analysis of the batch history records showed no anomaly during the manufacturing, control and packaging processes.Study of internal samples control charts: this analysis was carried out on four internal sample with different concentrations, on six batches including the batch mentioned by the customer.All the results were within specifications.Vidas rub igg ii batch 1006971560 / 191126-0 is in the trend compared to the other batches.Tests performed: the customer submitted two samples for evaluation.The laboratory performed a calibration and tested the two samples with retained kit vidas rub igg ii 1006971560 / 191126-0 on a vidas 3 instrument in automatic position.The two results were negative = 8 ui/ml.The laboratory performed tests with retained kit vidas rub igg ii 1006984570 / 191126-1 (same reagents and same mle data) on vidas 3 in automatic.The two results were negative = 9 ui/ml.The high result (55ui/ml) reported by the customer was not reproduced.Analysis of the logs: no problem or difference between aspirations performed by the pipettor were observed, considering all the sample positions, for all the rub igg ii analysis done between march 26 and april 17.No problem or difference between aspirations and dispensations performed by the section pumps were observed, for all the rub igg ii analysis done between march 26 and april 24.Conclusion: the investigation did not reproduced the customer's anomaly.The most probably hypothesis is a preanalytical issue during the first test as this result did not match with other negative results.According to the investigation results, vidas rub igg ii 1006971560 / 191126-0 performed as expected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® RUB IGG II
Type of Device
VIDAS® RUB IGG II
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280,
FR 
MDR Report Key8606427
MDR Text Key195711014
Report Number8020790-2019-00028
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 06/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/26/2019
Device Catalogue Number30221
Device Lot Number1006984570
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/17/2019
Initial Date FDA Received05/13/2019
Supplement Dates Manufacturer Received06/06/2019
Supplement Dates FDA Received06/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-